Literature DB >> 28789902

The role of hypernitrosylation in the pathogenesis and pathophysiology of neuroprogressive diseases.

Gerwyn Morris1, Ken Walder2, André F Carvalho3, Susannah J Tye4, Kurt Lucas5, Michael Berk6, Michael Maes7.   

Abstract

There is a wealth of data indicating that de novo protein S-nitrosylation in general and protein transnitrosylation in particular mediates the bulk of nitric oxide signalling. These processes enable redox sensing and facilitate homeostatic regulation of redox dependent protein signalling, function, stability and trafficking. Increased S-nitrosylation in an environment of increasing oxidative and nitrosative stress (O&NS) is initially a protective mechanism aimed at maintaining protein structure and function. When O&NS becomes severe, mechanisms governing denitrosylation and transnitrosylation break down leading to the pathological state referred to as hypernitrosylation (HN). Such a state has been implicated in the pathogenesis and pathophysiology of several neuropsychiatric and neurodegenerative diseases and we investigate its potential role in the development and maintenance of neuroprogressive disorders. In this paper, we propose a model whereby the hypernitrosylation of a range of functional proteins and enzymes lead to changes in activity which conspire to produce at least some of the core abnormalities contributing to the development and maintenance of pathology in these illnesses.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Apoptosis; NMDA; Neurogenesis; Neurology; Neuroprogression; Neurotrophin; Nitrosylation; Psychiatry; mTOR

Mesh:

Substances:

Year:  2017        PMID: 28789902     DOI: 10.1016/j.neubiorev.2017.07.017

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  10 in total

Review 1.  Role of Nitric Oxide and Hydrogen Sulfide in Ischemic Stroke and the Emergent Epigenetic Underpinnings.

Authors:  Parimala Narne; Vimal Pandey; Prakash Babu Phanithi
Journal:  Mol Neurobiol       Date:  2018-06-20       Impact factor: 5.590

Review 2.  Structure, Function, and Pharmacology of Glutamate Receptor Ion Channels.

Authors:  Kasper B Hansen; Lonnie P Wollmuth; Derek Bowie; Hiro Furukawa; Frank S Menniti; Alexander I Sobolevsky; Geoffrey T Swanson; Sharon A Swanger; Ingo H Greger; Terunaga Nakagawa; Chris J McBain; Vasanthi Jayaraman; Chian-Ming Low; Mark L Dell'Acqua; Jeffrey S Diamond; Chad R Camp; Riley E Perszyk; Hongjie Yuan; Stephen F Traynelis
Journal:  Pharmacol Rev       Date:  2021-10       Impact factor: 18.923

3.  In Schizophrenia, Deficits in Natural IgM Isotype Antibodies Including those Directed to Malondialdehyde and Azelaic Acid Strongly Predict Negative Symptoms, Neurocognitive Impairments, and the Deficit Syndrome.

Authors:  Michael Maes; Buranee Kanchanatawan; Sunee Sirivichayakul; André F Carvalho
Journal:  Mol Neurobiol       Date:  2018-11-27       Impact factor: 5.590

Review 4.  The Endoplasmic Reticulum Stress Response in Neuroprogressive Diseases: Emerging Pathophysiological Role and Translational Implications.

Authors:  Gerwyn Morris; Basant K Puri; Ken Walder; Michael Berk; Brendon Stubbs; Michael Maes; André F Carvalho
Journal:  Mol Neurobiol       Date:  2018-03-29       Impact factor: 5.590

5.  Subunit contribution to NMDA receptor hypofunction and redox sensitivity of hippocampal synaptic transmission during aging.

Authors:  Ashok Kumar; Jeffrey S Thinschmidt; Thomas C Foster
Journal:  Aging (Albany NY)       Date:  2019-07-24       Impact factor: 5.682

Review 6.  Endothelial dysfunction in neuroprogressive disorders-causes and suggested treatments.

Authors:  Gerwyn Morris; Basant K Puri; Lisa Olive; Andre Carvalho; Michael Berk; Ken Walder; Lise Tuset Gustad; Michael Maes
Journal:  BMC Med       Date:  2020-10-19       Impact factor: 8.775

Review 7.  Redox regulation of the immune response.

Authors:  Gerwyn Morris; Maria Gevezova; Victoria Sarafian; Michael Maes
Journal:  Cell Mol Immunol       Date:  2022-09-02       Impact factor: 22.096

8.  Increased Oxidative Stress Toxicity and Lowered Antioxidant Defenses in Temporal Lobe Epilepsy and Mesial Temporal Sclerosis: Associations with Psychiatric Comorbidities.

Authors:  Michael Maes; Thitiporn Supasitthumrong; Chusak Limotai; Ana Paula Michelin; Andressa Keiko Matsumoto; Laura de Oliveira Semão; João Victor de Lima Pedrão; Estefânia Gastaldello Moreira; Andre F Carvalho; Sunee Sirivichayakul; Décio Sabbatini Barbosa; Buranee Kanchanatawan
Journal:  Mol Neurobiol       Date:  2020-06-09       Impact factor: 5.682

Review 9.  Nutritional ketosis as an intervention to relieve astrogliosis: Possible therapeutic applications in the treatment of neurodegenerative and neuroprogressive disorders.

Authors:  Gerwyn Morris; Michael Maes; Michael Berk; André F Carvalho; Basant K Puri
Journal:  Eur Psychiatry       Date:  2020-01-31       Impact factor: 5.361

10.  Intersections between Copper, β-Arrestin-1, Calcium, FBXW7, CD17, Insulin Resistance and Atherogenicity Mediate Depression and Anxiety Due to Type 2 Diabetes Mellitus: A Nomothetic Network Approach.

Authors:  Hussein Kadhem Al-Hakeim; Hadi Hasan Hadi; Ghoufran Akeel Jawad; Michael Maes
Journal:  J Pers Med       Date:  2022-01-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.